NCT00366366
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
Clinical trial condition
Communicable Diseases
Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.
9,170 public trials
550 recruiting studies
Communicable Diseases trial results
NCT01878799
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01679964
- Conditions
- Adverse Drug Reaction, Blood-Borne Infections, Chemically-Induced Disorders, +16 more
- Locations
-
- E-Da Hospital Kaohsiung, Taiwan
- Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
- China Medical University Hospital Taichung, Taiwan
- National Cheng Kung University Hospital Tainan, Taiwan
NCT00952263
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
- Locations
-
- DaVita Clinical Research Minneapolis, Minnesota, United States
NCT02898922
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
- Locations
-
Not specified
NCT02808832
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
- Locations
-
- Meharry Medical College Nashville, Tennessee, United States
NCT02682108
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +16 more
- Locations
-
- Faculty of Medicine Siriraj Hospital Bangkoknoi, Bangkok, Thailand
NCT02097108
- Conditions
- Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +16 more
- Locations
-
- PMU Salzburg Salzburg, Austria
- AKH Wien Vienna, Austria
- Ottto Wagner Spital Vienna, Austria
NCT02785289
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
- Locations
-
- Geneva University Hospitals Geneva, Switzerland
Completed
Lamivudine(LAM) Good Responder Study
NCT01128686
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Kangwon-do, South Korea